Knight Campus Distinguished Lecture Series
The Knight Campus Distinguished Lecture is an annual event designed to bring nationally and internationally recognized science, technology and engineering leaders to the University of Oregon community to give their perspective on the future of their fields.
Director, Knight Cancer Institute
"Imatinib as a Paradigm of Targeted Cancer Therapies"
Brian Druker discussed how he spearheaded the highly successful clinical trials of imatinib for chronic myeloid leukemia, which led to FDA approval of the drug in record time.
CEO and Co-Founder, Chronicle
"Innovation, Leadership, and Change"
Stephen Gillett discussed leadership, transformation, and change and how these elements shaped him into a leader that skirts the norm, strives for innovation, and views change as an opportunity, not a roadblock.